Patents by Inventor Elango Minnoor

Elango Minnoor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7892840
    Abstract: Embodiments of the invention provide to apparatuses and media used in drug elution studies and methods for making and using them. One embodiment of the invention is a drug elution method that can be used for in-vitro studies of a matrix impregnated with a compound such as a drug blended polymer matrix. Such methods and materials can be used for example to assess and control the manufacturing process variability of drug eluting implantable devices such as cardiac leads.
    Type: Grant
    Filed: December 30, 2008
    Date of Patent: February 22, 2011
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Sarnath Chattaraj, Elango Minnoor, Eugene Levin, Poonam S. Gulati
  • Publication number: 20100162800
    Abstract: Embodiments of the invention provide to apparatuses and media used in drug elution studies and methods for making and using them. One embodiment of the invention is a drug elution method that can be used for in-vitro studies of a matrix impregnated with a compound such as a drug blended polymer matrix. Such methods and materials can be used for example to assess and control the manufacturing process variability of drug eluting implantable devices such as cardiac leads.
    Type: Application
    Filed: December 30, 2008
    Publication date: July 1, 2010
    Applicant: Medtronic MiniMed, Inc.
    Inventors: Sarnath Chattaraj, Elango Minnoor, Eugene Levin, Poonam S. Gulati
  • Publication number: 20060183178
    Abstract: Embodiments of the invention include polypeptide formulations and methods for making, using and characterizing them. Embodiment of the invention include stabilized polypeptide formulations, for example stable glucose oxidase formulations that can be used with glucose sensors used in the management of diabetes. Another embodiment of the invention includes methods to characterize the concentration of nonionic surfactants in stabilized polypeptide formulation for example stable insulin formulations that can be used in the treatment of diabetes.
    Type: Application
    Filed: February 17, 2005
    Publication date: August 17, 2006
    Inventors: Poonam Gulati, Sarnath Chattaraj, Elango Minnoor, Eugene Levin, Xiao Zhu, William Van Antwerp